Stock comparison
Drugs Made In America Acquisition II Corp. Ordinary Shares
Moody's
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
DMII
Drugs Made In America Acquisition II Corp. Ordinary Shares
Market cap
$528.3M
Sector
Financials
MCO
Moody's
Market cap
$78.46B
Sector
Financials
Overall winner
Moody's MCO
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | DMII | MCO | Winner |
|---|---|---|---|
| Warren Buffett | 16F | 71B | MCO |
| Benjamin Graham | 5F | 83A | MCO |
| Philip Fisher |
Side-by-side metrics
| Metric | DMII | MCO |
|---|---|---|
| Market cap | $528.3M | $78.46B |
| P/E (TTM) | 1.2x | 30.4x |
| EV/EBIT | - | 23.4x |
| ROIC (TTM) | -0.26% | 23.11% |
| Gross margin | 0.0% | 69.69% |
| Net margin | 0.0% | 31.69% |
| Revenue CAGR 5y | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
DMII leads on
- EV/EBIT-vs 23.4x+117%
- Debt / Equity-vs 2.4x+100%
- P/E (TTM)1.2xvs 30.4x+96%
MCO leads on
More like MCO
Related on invest-like
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.